$9.76
0.00 (0%)
ZymoGenetics, Inc. (NASDAQ:ZGEN)
CAPS Rating:
The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.
The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.